Preclinical study reveals enhanced antitumor efficacy via TBK1 modulation in CAR-T cells, suggesting a novel strategy to prevent cellular exhaustion.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Cattaneo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: